Gregory L. Cowan - 05 Jul 2023 Form 4 Insider Report for RVL Pharmaceuticals plc

Role
Director
Signature
/s/ Brian Markison, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
05 Jul 2023
Net transactions value
$0
Form type
4
Filing time
11 Jul 2023, 21:16:24 UTC
Previous filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Award $0 +40,000 +80% $0.000000 90,055 05 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units.

Remarks:

Exhibit 24.1 - Power of Attorney